Liver Tumors Clinical Trial
Official title:
A Phase II Study of Fractionated Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
Patients with primary hepato-biliary malignancies or liver metastases from gastrointestinal cancer suffer substantial morbidity and mortality from their hepatic disease. Curative resection is feasible only for selected subgroups of patients. The majority of patients have unresectable and incurable disease. Aggressive arterial and systemic chemotherapy have been used in recent years with improved response and survival. However, a significant number of patients, at least one-third of patients with liver metastases from colorectal cancer and two-third or higher of unresectable hepatobiliary cancer, continue to die of liver failure from progressive disease in the liver. Percutaneous ethanol injections, chemoembolization, cryotherapy and thermal ablation using radiofrequency have been used to treat selected patients with smaller tumors (3-4 cm) in areas away from major blood vessels and the biliary tract. However, most unresectable liver cancers did not fit the criteria for these treatments. Therefore, other regional therapeutic option like external radiation therapy may be considered for local control in the liver or symptom palliation
n/a
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01197820 -
Hepatic and Renal Thermography Using Magnetic Resonance Imaging
|
N/A | |
| Terminated |
NCT00942383 -
Freehand Ultrasound Elasticity Imaging in Liver Surgery
|
||
| Completed |
NCT01782573 -
The Efficacy of Chlorhexidine Gluconate Pre - Disinfection Scrubbing in Preventing Surgical Site Infections for Hepatectomy Patients
|
Phase 4 | |
| Active, not recruiting |
NCT03432806 -
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
|
||
| Completed |
NCT01403727 -
Electromagnetic Tracking of Devices During Biopsy Procedures
|
N/A | |
| Terminated |
NCT00955097 -
Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors
|
Phase 1 | |
| Recruiting |
NCT02184182 -
Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy (LAPS)
|
Phase 2 | |
| Completed |
NCT02162732 -
Molecular-Guided Therapy for Childhood Cancer
|
N/A | |
| Recruiting |
NCT05990257 -
CMRA for US-guided-MWA of Liver Tumors
|
N/A | |
| Completed |
NCT00828607 -
Contrast Enhanced (CE) Ultrasound and CE Computed Tomography or CE Magnetic Resonance Imaging in Liver Masses
|
N/A | |
| Completed |
NCT00960609 -
Communicating Veins Between Adjacent Hepatic Veins: an Intra-operative Ultrasound Study
|
N/A | |
| Completed |
NCT05445973 -
Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency Ablation
|
N/A | |
| Completed |
NCT03171428 -
Hepatectomy With or Without the Thoraco-abdominal Approach
|
N/A | |
| Completed |
NCT02509507 -
Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611
|
Phase 1/Phase 2 | |
| Completed |
NCT00877136 -
A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
|
||
| Recruiting |
NCT04315883 -
Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
|
||
| Completed |
NCT01031784 -
Radioactive Holmium Microspheres for the Treatment of Liver Metastases
|
Phase 1 | |
| Active, not recruiting |
NCT00845689 -
Prevention of Liver Damage During Liver Surgery
|
Phase 1/Phase 2 |